iVeena Alternatives & Competitors

12 companies similar to iVeena — Lead programs comprise of novel proprietary eye drops; IVMED-80 (granted ODD) fo...

Epion Therapeutics

A clinical-stage company developing a minimally-invasive treatment for keratoconus

12 Series A $32.00M

Burlington, United States

Biotechnology Health Care +3

BAROnova

A clinical-stage medical-device company innovating non-surgical, non-pharmacologic solutio...

4 Debt Financing $85.90M

Biotechnology Health Care +2

Cognito Therapeutics, Inc.

Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerati...

53 Series B $216.77M

Cambridge, United States

Biotechnology Health Care +2

Salutaris Medical Devices

Pioneering breakthroughs in treating eye diseases with precision radiotherapy.

3 Venture round $5.87M

Tucson, United States

Biotechnology Health Care +1

Track all iVeena competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

CytoPherx, Inc.

Pioneering medical advancements to combat inflammation-based diseases with innovative sele...

2 Series C $50.20M

Ann Arbor, United States

Health Care Life Sciences +1

Athersys

Committed to developing therapies to extend and enhance the quality of life.

37 Post-IPO Equity $208.90M

Cleveland, United States

Biopharma Biotechnology +2

Perceive Biotherapeutics, Inc.

20 Series B $78.00M

South San Francisco, Unit...

Biopharma Biotechnology +2

Alkeus Pharmaceuticals, Inc.

Transformation in Sight

58 Series B $150.10M

Biotechnology Medical Devices +1

LENTECHS

Developing a new generation of soft, suspended contact lens

9 Venture round $11.07M

Columbus, United States

Biotechnology Health Care +1

Cognoptix

The Eye Scan for Alzheimer's Early Insight

3 Venture round $46.35M

Marlborough, United State...

Biotechnology Health Care +2

JuneBrain Inc.

Empowering eye care and neurology communities through remote monitoring of disease.

13 Non Equity Assistance $1.51M

Baltimore, United States

Biotechnology Health Care +1

GI Windows Surgical

Engineering less invasive solutions for both surgeons and patients.

21 Venture round $57.38M

United States

Biotechnology Health Care +1

About iVeena

is a biotechnology startup founded in 2006 and headquartered in the United States. The company's slogan, "Lead programs comprise of novel proprietary eye drops; IVMED-80 (granted ODD) for keratoconus, and IVMED-85 for myopia," highlights its focus on developing non-surgical, non-invasive, and pharmacologic innovations...

Taxonomy

Ophthalmology, Clinical Stage, Non-surgical, Non-invasive, Pharmacologic Innovation, Disease Modifying Intervention, Keratoconus, Myopia, Proprietary Eye Drops, IVMED-80, IVMED-85, Corneal Diseases, Myopic Conditions

Frequently Asked Questions

Companies similar to iVeena include Epion Therapeutics, BAROnova, Cognito Therapeutics, Inc., Salutaris Medical Devices, CytoPherx, Inc.. They work in Biotechnology and Medical Devices and share iVeena's focus on ophthalmology, corneal diseases and keratoconus.

Bounce Watch lists 12 companies that share iVeena's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches iVeena and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

iVeena Profile BAROnova Alternatives Cognito Therapeutics, Inc. Alternatives CytoPherx, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at iVeena on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.